{"id":62354,"date":"2016-02-03T10:47:21","date_gmt":"2016-02-03T07:47:21","guid":{"rendered":"https:\/\/www.17047165566933.sritis.lt\/index.php\/2016\/02\/03\/kokiu-kompensuojamuju-vaistu-vaistines-privalo-tureti-kasdien\/"},"modified":"2016-02-03T10:47:21","modified_gmt":"2016-02-03T07:47:21","slug":"kokiu-kompensuojamuju-vaistu-vaistines-privalo-tureti-kasdien","status":"publish","type":"post","link":"https:\/\/www.santaka.info\/index.php\/2016\/02\/03\/kokiu-kompensuojamuju-vaistu-vaistines-privalo-tureti-kasdien\/","title":{"rendered":"Koki\u0173 kompensuojam\u0173j\u0173 vaist\u0173 vaistin\u0117s privalo tur\u0117ti kasdien?"},"content":{"rendered":"<p><em>Irena D\u017eiu\u017eait\u0117<\/em><\/p>\n<p> <br \/>\nValstybin\u0117 ligoni\u0173 kasa (VLK) primena, kad visos vaistin\u0117s, sudariusios sutartis su ligoni\u0173 kasomis, visada privalo tur\u0117ti ir pacientui pasi\u016blyti vaist\u0173 bei medicinos pagalbos priemoni\u0173 (MPP), \u012fra\u0161yt\u0173 \u012f Vaistin\u0117je b\u016btin\u0173 tur\u0117ti kompensuojam\u0173j\u0173 vaist\u0173 ir MPP s\u0105ra\u0161us.  <br \/> <br \/>\n\u0160iuo metu \u012f Vaistin\u0117je b\u016btin\u0173 tur\u0117ti kompensuojam\u0173j\u0173 vaist\u0173 s\u0105ra\u0161\u0105 yra \u012ftrauktos 65 bendrini\u0173 pavadinim\u0173 vaist\u0173 grup\u0117s. Jame \u012fra\u0161yti: kraujosp\u016bd\u012f ma\u017einantys, skausm\u0105 mal\u0161inantys, \u0161irdies veikl\u0105 gerinantys vaistai, antibiotikai infekcin\u0117ms ligoms gydyti, vaistai nuo cukrinio diabeto, astmos, pernelyg didelio akisp\u016bd\u017eio ir kiti. Vaistin\u0117se taip pat privalu tur\u0117ti pigiausi\u0173 ir da\u017eniausiai naudojam\u0173 MPP: diagnostini\u0173 juosteli\u0173 gliukoz\u0117s kiekiui kraujyje nustatyti, sauskelni\u0173 suaugusiesiems. Pacientams, \u012fsigyjantiems j\u0173 su kompensuojam\u0173j\u0173 vaist\u0173 pasu, svarbu \u017einoti, kad \u012f \u0161iuos s\u0105ra\u0161us patenka da\u017eniausiai skiriami kompensuojamieji vaistai ir MPP, kuri\u0173 priemoka yra ma\u017eiausia ir kurie vaistin\u0117je turi b\u016bti pasi\u016blomi pirmiausia.  <br \/> <br \/>\n&bdquo;Svarbu \u017einoti, kad vaistus, kuri\u0173 veiklioji med\u017eiaga ta pati, pasibaigus patento galiojimo laikotarpiui pradeda gaminti \u012fvairios farmacijos kompanijos. Tokie vaistai turi vien\u0105 t\u0105 pat\u012f vaisto veikliosios med\u017eiagos bendrin\u012f pavadinim\u0105, ta\u010diau j\u0173 gamintojai suteikia jiems skirtingus firminius pavadinimus. Tai tarsi b\u016bt\u0173 skirtingi to paties \u017emogaus vardai. Suprantama, kad skiriasi ir vaist\u0173 firminiais pavadinimais kainos, tod\u0117l vaistininko pareiga yra pirmiausia pasi\u016blyti pacientui \u012fsigyti t\u0105 kompensuojam\u0105j\u012f vaist\u0105, kuriam taikoma ma\u017eiausia priemoka. Ligoni\u0173 kasa sudaro Vaistin\u0117je b\u016btin\u0173 tur\u0117ti kompensuojam\u0173j\u0173 vaist\u0173 s\u0105ra\u0161\u0105, kad vaistininkai \u017einot\u0173, kurie da\u017eniausiai pacientams reikalingi kompensuojamieji vaistai yra pigiausi ir kuri\u0173 i\u0161 j\u0173 vaistin\u0117je turi b\u016bti visada&quot;, &ndash; teig\u0117 VLK Vaist\u0173 kompensavimo skyriaus ved\u0117ja Kristina Garuolien\u0117.  <br \/> <br \/>\nVaistin\u0117je visada turi b\u016bti pakankamai \u012f b\u016btin\u0173 tur\u0117ti s\u0105ra\u0161us \u012fra\u0161yt\u0173 kompensuojam\u0173j\u0173 vaist\u0173 ir MPP, kad pacientas i\u0161 karto gal\u0117t\u0173 juos \u012fsigyti, i\u0161skyrus tuos atvejus, kai vaistin\u0117 pra\u0117jus\u012f met\u0173 ketvirt\u012f tokio bendrinio pavadinimo ir atitinkamo stiprumo, koks yra s\u0105ra\u0161e, vaist\u0173 ar tokios pa\u010dios MPP nepardav\u0117 arba kurie buvo laikinai netiekiami Lietuvos rinkai. Ta\u010diau ir tokiu atveju vaistin\u0117 privalo tur\u0117ti pakankamai pigiausi\u0173 bet kokio kito stiprumo \u0161io bendrinio pavadinimo vaist\u0173 ir bet kokio pana\u0161aus dyd\u017eio \u0161ios paskirties MPP, kuri\u0173 per pastaruosius tris m\u0117nesius buvo parduota daugiausiai.  <\/p>\n<p>Vaistin\u0117je b\u016btin\u0173 tur\u0117ti kompensuojam\u0173j\u0173 vaist\u0173 bei MPP s\u0105ra\u0161ai nuolat kinta, nes kei\u010diasi kompensuojam\u0173j\u0173 vaist\u0173 bei MPP kainos. Taip siekiama u\u017etikrinti, kad privalomuoju sveikatos draudimu apdrausti \u017emon\u0117s tur\u0117t\u0173 daugiau galimybi\u0173 be joki\u0173 sunkum\u0173 \u012fsigyti kompensuojam\u0173j\u0173 vaist\u0173, kuri\u0173 didel\u0117 kainos dalis ar net visa kaina yra kompensuojama i\u0161 Privalomojo sveikatos draudimo fondo biud\u017eeto.  <\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Irena D\u017eiu\u017eait\u0117 Valstybin\u0117 ligoni\u0173 kasa (VLK) primena, kad visos vaistin\u0117s, sudariusios sutartis su ligoni\u0173 kasomis, visada privalo tur\u0117ti ir pacientui pasi\u016blyti vaist\u0173 bei medicinos pagalbos priemoni\u0173 (MPP), \u012fra\u0161yt\u0173 \u012f Vaistin\u0117je&#8230; <\/p>\n","protected":false},"author":1,"featured_media":62355,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pmpro_default_level":"","jetpack_post_was_ever_published":false,"_FSMCFIC_featured_image_caption":" \/ VLK nuotrauka.","_FSMCFIC_featured_image_nocaption":"","_FSMCFIC_featured_image_hide":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-62354","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","pmpro-has-access"],"featured_image_urls":{"full":["https:\/\/www.santaka.info\/wp-content\/uploads\/2024\/12\/20160203104721.jpg",900,675,false],"thumbnail":["https:\/\/www.santaka.info\/wp-content\/uploads\/2024\/12\/20160203104721-150x150.jpg",150,150,true],"medium":["https:\/\/www.santaka.info\/wp-content\/uploads\/2024\/12\/20160203104721-300x225.jpg",300,225,true],"medium_large":["https:\/\/www.santaka.info\/wp-content\/uploads\/2024\/12\/20160203104721-768x576.jpg",768,576,true],"large":["https:\/\/www.santaka.info\/wp-content\/uploads\/2024\/12\/20160203104721.jpg",900,675,false],"1536x1536":["https:\/\/www.santaka.info\/wp-content\/uploads\/2024\/12\/20160203104721.jpg",900,675,false],"2048x2048":["https:\/\/www.santaka.info\/wp-content\/uploads\/2024\/12\/20160203104721.jpg",900,675,false],"post-thumbnail":["https:\/\/www.santaka.info\/wp-content\/uploads\/2024\/12\/20160203104721-600x400.jpg",600,400,true],"visualnews_post_thumb":["https:\/\/www.santaka.info\/wp-content\/uploads\/2024\/12\/20160203104721-600x400.jpg",600,400,true],"woocommerce_thumbnail":["https:\/\/www.santaka.info\/wp-content\/uploads\/2024\/12\/20160203104721-300x300.jpg",300,300,true],"woocommerce_single":["https:\/\/www.santaka.info\/wp-content\/uploads\/2024\/12\/20160203104721-600x450.jpg",600,450,true],"woocommerce_gallery_thumbnail":["https:\/\/www.santaka.info\/wp-content\/uploads\/2024\/12\/20160203104721-100x100.jpg",100,100,true]},"author_info":{"info":["admin"]},"category_info":"<a href=\"https:\/\/www.santaka.info\/index.php\/category\/uncategorized\/\" rel=\"category tag\">Be kategorijos<\/a>","tag_info":"Be kategorijos","comment_count":"0","jetpack_featured_media_url":"https:\/\/www.santaka.info\/wp-content\/uploads\/2024\/12\/20160203104721.jpg","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/posts\/62354","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/comments?post=62354"}],"version-history":[{"count":0,"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/posts\/62354\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/media\/62355"}],"wp:attachment":[{"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/media?parent=62354"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/categories?post=62354"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.santaka.info\/index.php\/wp-json\/wp\/v2\/tags?post=62354"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}